Warner Roberts Appointed Chief Commercial Officer to Accelerate Growth and Innovation

New York, [April 16] — Calibrate, the leader in comprehensive obesity treatment, is pleased to announce Warner Roberts will assume the role of Chief Commercial Officer (CCO).

In this expanded role, Roberts will continue to drive Calibrate’s commercial strategy, helping to scale the company’s innovative solutions to meet the increasing demand for effective workplace obesity treatment.

With more than 42% of U.S. adults affected by obesity and its growing link to healthcare costs, absenteeism, and chronic disease, the need for comprehensive obesity treatment has never been more urgent. Calibrate is well-positioned to meet market demands, as highlighted by its recent annual results, which show that members have achieved an impressive 19% average sustained weight loss over 36 months.

“Warner is an invaluable member of the Calibrate team, and his leadership plays a critical part in our success,” said Rob MacNaughton, CEO of Calibrate. “As we continue to scale and grow, his deep understanding of commercial strategy and operations and his commitment to delivering long-term, impactful results make him the ideal leader. We’re confident that under Warner’s stewardship, Calibrate will continue to thrive and transform the way obesity is treated.”

"I’ve had the privilege of working with organizations dedicated to solving major health challenges, and what excites me most about Calibrate is its focused, results-driven approach," said Warner Roberts, Chief Commercial Officer of Calibrate. “By combining clinically backed obesity medications with behavior change programming, we’re delivering measurable, long-term results that truly make a difference. I’m honored to take on this expanded role and help drive Calibrate’s mission forward, ensuring that we continue to deliver real, lasting change for individuals and businesses alike.”

About Calibrate

At Calibrate, we’re changing the way the world treats weight with a clinically proven, outcomes-guaranteed program that delivers sustained weight loss and long-term healthcare savings. Unlike GLP-1-only approaches that lead to weight regain and wasted investment, Calibrate integrates medication, expert clinical care, and personalized behavior change to drive lasting results.

With board-certified obesity medicine physicians prescribing in all 50 states, we provide nationwide, equitable access to effective obesity treatment at scale. Our risk-sharing model ensures that we’re aligned with employer goals—putting fees at risk and guaranteeing measurable outcomes.

By addressing obesity as the root cause of chronic conditions like diabetes, hypertension, sleep apnea, and cardiovascular disease, Calibrate reduces overall healthcare costs while improving